BioSpace News Archive

The National Health Care Anti-Fraud Association (NHCAA) today announced that Roger I. Purnell, AHFI, CFE, Director of the Special Investigations Unit (SIU) at BlueCross BlueShield of North Carolina (BCBSNC), has been elected as Chair of the NHCAA Board of Directors.

Aura Biosciences, a leader in the development of novel targeted therapies in ocular oncology, today announced that updated clinical data from its Phase 1b/2 clinical trial evaluating the safety and efficacy of light-activated AU-011,

Florida Southern College broke ground on its new School of Physical Therapy, a stunningly designed facility that will supply highly trained physical therapists to healthcare facilities in central Florida and beyond.

Horizon Pharma plc announced that more detailed results from the 48 week off-therapy follow-up to the Phase 2 clinical trial of teprotumumab for people living with moderate-to-severe active thyroid eye disease (TED) were presented at the American Academy of Ophthalmology (AAO) Annual Meeting, Oct. 27 – 30, 2018, in Chicago, Ill.

vTv Therapeutics Inc. today announced that The NASDAQ Stock Market LLC (“Nasdaq”) has approved the Company’s application to list its Class A Common Stock on The Nasdaq Capital Market.

Awad, Calnon & Serio Add to the Firm’s Expertise in Health Care Advocacy, Media Relations

Truth Initiative® Releases Data from a First-of-Its-Kind Study that Explores the Rates and Characteristics of JUUL Use

Medicare Advantage Plan Offers HMO and PPO Plans With $0 Premiums, $0 Co-Pays and $0 Deductibles in Nine North Texas Counties; Coverage Also Includes Enhanced Dental, Vision and Hearing Benefits

Many Americans are afraid that they won’t be able to get health insurance if the Affordable Care Act (ACA) is repealed because they have a pre-existing condition.

Funds Raised Will Help Accelerate Innovative Cancer Research as Part of CVS Health’s Commitment to Building Healthier Communities